L-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma.

@article{Yong2003LasparaginasebasedRI,
  title={L-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma.},
  author={Weiben Yong and Wen Zheng and Yuntao Zhang and Jun Zhu and Yan Fei Wei and Deliang Zhu and Jiyou Li},
  journal={International journal of hematology},
  year={2003},
  volume={78 2},
  pages={163-7}
}
Nasal, nasal-type T-cell/natural killer cell (T/NK-cell) lymphoma is a rare disease, and its prognosis is poor. Between March 1992 and March 2002 we investigated a new L-asparaginase-based salvage regimen to treat the disease and improve response to treatment and 5-year overall survival rate. Eighteen patients with refractory midline nasal, nasal-type T/NK… CONTINUE READING